Hem › Wilms tumör
Kliniska studier för Wilms tumör som rekryterar i USA
17 studier för Wilms tumör rekryterar deltagare vid platser över hela USA.
Städer med flest studier
- Washington, DC7 studier
- Memphis, TN6 studier
- Atlanta, GA5 studier
- Chicago, IL4 studier
- Los Angeles, CA4 studier
- Boston, MA4 studier
- Greenburgh, NY4 studier
- St. Louis, MO4 studier
- Cincinnati, OH4 studier
- New York City, NY4 studier
- Mountain View, CA4 studier
- Houston, TX4 studier
- Philadelphia, PA4 studier
- Minneapolis, MN4 studier
- Aurora, CO4 studier
- Ann Arbor, MI3 studier
- Birmingham, AL3 studier
Efter delstat
- Alabama3 studier
- Colorado4 studier
- District of Columbia7 studier
- Florida3 studier
- Georgia5 studier
- Illinois4 studier
- Kalifornien5 studier
- Massachusetts4 studier
- Michigan3 studier
- Minnesota5 studier
- Missouri4 studier
- New York6 studier
- Ohio5 studier
- Pennsylvania4 studier
- Tennessee6 studier
- Texas6 studier
Nyligen uppdaterade studier
Officiell studietext (engelska)
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
RekryterarFas 2
Ålder 12 till 39 · Alla kön · Uppdaterad 29 sep. 2026 · NCT04616560Biomarkers of Resiliency In Childhood Cancer Surgery
RekryterarObservationsstudie
Ålder 3 till 25 · Alla kön · Uppdaterad 14 sep. 2026 · NCT06674811A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
RekryterarFas 2
Upp till ålder 30 · Alla kön · Uppdaterad 25 aug. 2026 · NCT04322318Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
RekryterarFas 1/2
12 Months – 30 Years · Alla kön · Uppdaterad 25 aug. 2026 · NCT04851119Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE)
RekryterarFas 1
Ålder 1 till 23 · Alla kön · Uppdaterad 13 aug. 2026 · NCT07172958Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors
RekryterarFas 1
Ålder 1 till 21 · Alla kön · Uppdaterad 6 aug. 2026 · NCT04715191Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors
RekryterarFas 1/2
6 Months – 25 Years · Alla kön · Uppdaterad 30 juni 2026 · NCT06625190B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
RekryterarFas 1
Upp till ålder 21 · Alla kön · Uppdaterad 19 maj 2026 · NCT04897321Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
RekryterarFas 1/2
12 Months – 30 Years · Alla kön · Uppdaterad 19 maj 2026 · NCT04901702A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors
RekryterarFas 2
12 Months · Alla kön · Uppdaterad 6 maj 2026 · NCT05985161Treatment of Newly Diagnosed Patient's With Wilm's Tumor Requiring Abdominal Radiation Delivered With Proton Beam Irradiation
RekryterarFas 2
Alla åldrar · Alla kön · Uppdaterad 23 apr. 2026 · NCT04968990Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies
RekryterarFas 1
Ålder 1 till 30 · Alla kön · Uppdaterad 15 apr. 2026 · NCT04308330Pencil Beam Scanning in Patients With Renal Tumors
RekryterarTidig fas 1
Ålder 0 till 30 · Alla kön · Uppdaterad 15 apr. 2026 · NCT03810651Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells
RekryterarFas 1
Ålder 1 till 26 · Alla kön · Uppdaterad 17 feb. 2026 · NCT07148050Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells
RekryterarFas 1
Upp till ålder 21 · Alla kön · Uppdaterad 3 nov. 2025 · NCT06198296A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
RekryterarFas 2
18 Months – 40 Years · Alla kön · Uppdaterad 12 aug. 2025 · NCT05135975International PPB/DICER1 Registry
RekryterarObservationsstudieFriska volontärer välkomna
0 Minutes – 100 Years · Alla kön · Uppdaterad 30 jan. 2025 · NCT03382158Från ClinicalTrials.gov, data hämtad 3 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.